Bosh sahifaGUD • TSE
add
Knight Therapeutics Inc
Yopilish kursi
7,67 $
Kunlik diapazon
7,61 $ - 7,71 $
Yillik diapazon
5,50 $ - 7,74 $
Bozor kapitalizatsiyasi
751,63 mln CAD
Oʻrtacha hajm
91,99 ming
Narx/foyda
-
Dividend daromadliligi
-
Asosiy maydon
TSE
Bozor yangiliklari
Moliyaviy axborot
Moliyaviy hisobot
Daromad
Sof foyda
| (CAD) | dek, 2025info | Y/Y qiyosi |
|---|---|---|
Daromad | 133,11 mln | 37,42% |
Joriy xarajat | 58,51 mln | 35,10% |
Sof foyda | 8,85 mln | -17,52% |
Sof foyda marjasi | 6,65 | -39,98% |
Har bir ulushga tushum | 0,10 | -4,73% |
EBITDA | 16,47 mln | 154,91% |
Amaldagi soliq stavkasi | 21,12% | — |
Balans
Jami aktivlari
Jami passivlari
| (CAD) | dek, 2025info | Y/Y qiyosi |
|---|---|---|
Naqd pul va qisqa investitsiyalar | 114,23 mln | -33,91% |
Jami aktivlari | 1,05 mlrd | 8,56% |
Jami passivlari | 279,03 mln | 65,41% |
Umumiy kapital | 767,27 mln | — |
Tarqatilgan aksiyalar | 98,03 mln | — |
Narxi/balansdagi bahosi | 0,99 | — |
Aktivlardan daromad | 1,48% | — |
Kapitaldan daromad | 1,81% | — |
Pul aylanmasi
Naqd pulning sof oʻzgarishi
| (CAD) | dek, 2025info | Y/Y qiyosi |
|---|---|---|
Sof foyda | 8,85 mln | -17,52% |
Operatsiyalardan naqd pul | 34,87 mln | 2 273,86% |
Sarmoyadan naqd pul | -4,58 mln | -125,40% |
Moliyadan naqd pul | -34,80 mln | -126,64% |
Naqd pulning sof oʻzgarishi | -5,43 mln | -185,45% |
Boʻsh pul | 33,32 mln | 571,65% |
Haqida
Knight Therapeutics Inc. is a Canadian public specialty pharmaceutical company based in Montreal, Quebec that focuses on acquiring or in-licensing innovative pharmaceutical products for the Canadian and select international markets. It is listed on the Toronto Stock Exchange, with a market capitalization of $1.02 billion as of August 2019. Wikipedia
Tashkil etilgan
2014
Bosh ofis
Sayt
Xodimlar soni
830
